Dihydrotestosterone(DHT)
CAS No. 521-18-6
Dihydrotestosterone(DHT) ( androstanolone;stanolone;5α-DHT )
Catalog No. M20270 CAS No. 521-18-6
Dihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 66 | In Stock |
|
25MG | 126 | In Stock |
|
50MG | 212 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDihydrotestosterone(DHT)
-
NoteResearch use only not for human use.
-
Brief DescriptionDihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
-
DescriptionDihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
-
Synonymsandrostanolone;stanolone;5α-DHT
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaMetabolic Disease
-
IndicationHypogonadism
Chemical Information
-
CAS Number521-18-6
-
Formula Weight290.44
-
Molecular FormulaC19H30O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL (172.15 mM);Ethanol: 50 mg/mL (172.15 mM);Water:Insoluble
-
SMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
-
Chemical Name5-alpha-Androstan-3-one 17-beta-hydroxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zheng Y et al. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Endocr Relat Cancer. 2011 Jul 4;18(4):451-64.
molnova catalog
related products
-
Boldenone undecylena...
A synthetic, anabolic-androgenic steroid (AAS) and androgen ester that is used in veterinary medicine, a long-acting ester of boldenone.
-
Danazol
Danazol is a derivative of the synthetic steroid ethisterone.
-
YK11
YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM with osteogenic activity.